Attending Genomic Approaches to Define Tumor Biology and Clinical Stratification at #AACR26 today? See the paper by Thangavadivel and colleagues linking immune dysfunction to therapeutic ibrutinib resistance in patients with CLL. https://t.co/mYHLylgbZX